Biologics, Biosimilars and Patents: A Beginner’s Guide
Given the recent history of the BPCIA and the ongoing understanding of how the regulatory aspects are working in practice, including the multiple types of biologic products that are covered by the law, it can seem quite a complicated system for those not in the business. It is with this in mind that we created…
I-MAK & AELP: The Costs of Pharma Cheating
Lowering Prescription Drug Costs by Removing Barriers to Challenging Patents
Imbruvica’s Patent Wall
The Patent System is a Bottleneck for Medicines
Pharmaceutical Patent Myths
Overpatented, Overpriced: Enbrel Special Edition
Overpatented, Overpriced: Lantus Special Edition
Overpatented, Overpriced: Special Humira Edition
Overpatented, Overpriced: How Excessive Pharmaceutical Patenting is Extending Monopolies and Driving up Drug Prices
Partner with us now to build
a more just and equitable
medicine system for all.